Dexamethasone-Associated Hyperglycemia is Not Associated With Infectious Complications After Total Joint Arthroplasty in Diabetic Patients
The Journal of Arthroplasty · 2024
DOI: 10.1016/j.arth.2024.01.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Arthroplasty, 2024. Verfasst von Ian A Jones und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology & Pain Medicine, University of Washington, Seattle, Washington. Hauptthemen laut MEDLINE: Dexamethasone, Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee, Hyperglycemia. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Postoperative infection is a devastating complication of total joint arthroplasty (TJA). Perioperative use of dexamethasone in patients who have diabetes mellitus (DM) remains controversial due to concern for increased infection risk. This study aimed to evaluate the association between dexamethasone and infection risk among patients who have DM undergoing TJA. METHODS: This was a retrospective cohort study conducted on adult patients who underwent primary, elective total knee arthroplasty (TKA) or total hip arthroplasty (THA) between January 2016 and December 2021 using a large national database. We identified 110,568 TJA patients (TKA: 66.6%; THA: 33.4%), 31.0% (34,298) of which had DM. Patients who received perioperative dexamethasone were compared to those who did not. The primary end points were the 90-day risk of postoperative periprosthetic joint infection, surgical site infection (SSI), and other non-SSI (urinary tract infection, pneumonia, sepsis). RESULTS: When modeling the association between dexamethasone exposure and study outcomes while accounting for the interaction between dexamethasone and morning blood glucose levels, dexamethasone administration conferred no increased odds of postoperative periprosthetic joint infection nor SSI in diabetics. However, dexamethasone significantly lowered the adjusted odds of other postoperative infections in diabetic patients (TKA: adjusted odds ratio = 09, 95% confidence interval = 0.8 to 1.0, P = .030; THA: adjusted odds ratio = 0.7, 95% confidence interval = 0.6 to 0.9, P = .001); specifically in patients with morning blood glucose levels between 110 to 248 mg/dL in TKA and ≤ 172 mg/dL in THA. CONCLUSIONS: This study provides strong evidence against withholding dexamethasone in diabetic patients undergoing TJA based on concern for infection. Instead, short-course perioperative dexamethasone reduced infection risk in select patients. The narrative surrounding dexamethasone should shift away from questions about whether dexamethasone is appropriate for diabetic patients, and instead focus on how best to optimize its use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anaesthesiology & Pain Medicine, University of Washington, Seattle, Washington.
- Department of Orthopaedic Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, California.
Zitieren
APA
Jones, I. A., Wier, J., Liu, K. C., Richardson, M. K., Yoshida, B., Palmer, R., Lieberman, J. R., & Heckmann, N. D. (2024). Dexamethasone-Associated Hyperglycemia is Not Associated With Infectious Complications After Total Joint Arthroplasty in Diabetic Patients. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2024.01.025
Vancouver
Jones IA, Wier J, Liu KC, Richardson MK, Yoshida B, Palmer R, et al. Dexamethasone-Associated Hyperglycemia is Not Associated With Infectious Complications After Total Joint Arthroplasty in Diabetic Patients. The Journal of Arthroplasty. 2024. doi:10.1016/j.arth.2024.01.025
BibTeX
@article{Jones2024,
author = {Jones, Ian A and Wier, Julian and Liu, Kevin C and Richardson, Mary K and Yoshida, Brandon and Palmer, Ryan and Lieberman, Jay R and Heckmann, Nathanael D},
title = {Dexamethasone-Associated Hyperglycemia is Not Associated With Infectious Complications After Total Joint Arthroplasty in Diabetic Patients},
journal = {The Journal of Arthroplasty},
year = {2024},
doi = {10.1016/j.arth.2024.01.025}
}
EUVIMED